Antivirals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066602
  • May 2021
  • Pharmaceuticals
  • 118 Pages
The Antivirals Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Boehringer Ingelheim GmbH, Bristol-Myers-Squibb, Broad Institute, F. Hoffmann-La Roche, GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mylan N.V, Novartis AG
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Antivirals market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Antivirals market is expected to attain Pre COVID-19 levels by mid-2022.

Antivirals Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Antivirals market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Antivirals Market Competitive and Premeditated Analysis
In the Antivirals report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Antivirals research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Antivirals Market:
The Antivirals market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Boehringer Ingelheim GmbH, Bristol-Myers-Squibb, Broad Institute, F. Hoffmann-La Roche, GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mylan N.V, Novartis AG

The Antivirals market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Antivirals Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Antivirals market:
By Product
Bipolar Electrosurgical Devices
Electrosurgical Generator Systems
End User
Hospitals
Clinics
Ambulatory Surgical Centers
ASCs

Regional Analysis of the Antivirals market:
The Antivirals market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Antivirals report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Antivirals market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Antivirals market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Antivirals market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Antivirals market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Antivirals market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Antivirals market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Antivirals market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Antivirals market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Boehringer Ingelheim GmbH
  • Bristol-Myers-Squibb
  • Broad Institute
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mylan N.V
  • Novartis AG
  • Bipolar Electrosurgical Devices
  • Electrosurgical Generator Systems
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • ASCs

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Antivirals Market Snapshot
          2.1.1. Global Antivirals Market By Product,2019
               2.1.1.1.Bipolar Electrosurgical Devices
               2.1.1.2.Electrosurgical Generator Systems
          2.1.2. Global Antivirals Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Clinics
               2.1.2.3.Ambulatory Surgical Centers
               2.1.2.4.ASCs
          2.1.3. Global Antivirals Market By End-use,2019
          2.1.4. Global Antivirals Market By Geography,2019

3. Global Antivirals Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Antivirals Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Antivirals Market Size (US$), By Product, 2018 – 2028

5. Global Antivirals Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Antivirals Market Size (US$), By End User, 2018 – 2028

6. Global Antivirals Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Antivirals Market Size (US$), By End-use, 2018 – 2028

7. Global Antivirals Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Antivirals Market Analysis, 2018 – 2028 
          7.2.1. North America Antivirals Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Antivirals Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Antivirals Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Antivirals Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Antivirals Market Analysis, 2018 – 2028 
          7.3.1.  Europe Antivirals Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Antivirals Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Antivirals Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Antivirals Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Antivirals Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Antivirals Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Antivirals Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Antivirals Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Antivirals Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Antivirals Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Antivirals Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Antivirals Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Antivirals Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Antivirals Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Antivirals Market Analysis, 2018 – 2028 
          7.6.1.  MEA Antivirals Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Antivirals Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Antivirals Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Antivirals Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Antivirals Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Boehringer Ingelheim GmbH
                8.4.2.1 Business Description
                8.4.2.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.2.3 Boehringer Ingelheim GmbH Financial Information
                8.4.2.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.2.5 Boehringer Ingelheim GmbH Key Developments
        8.4.3 Bristol-Myers-Squibb
                8.4.3.1 Business Description
                8.4.3.2 Bristol-Myers-Squibb Geographic Operations
                8.4.3.3 Bristol-Myers-Squibb Financial Information
                8.4.3.4 Bristol-Myers-Squibb Product Positions/Portfolio
                8.4.3.5 Bristol-Myers-Squibb Key Developments
        8.4.4 Broad Institute
                8.4.4.1 Business Description
                8.4.4.2 Broad Institute Geographic Operations
                8.4.4.3 Broad Institute Financial Information
                8.4.4.4 Broad Institute Product Positions/Portfolio
                8.4.4.5 Broad Institute Key Developments
        8.4.5 F. Hoffmann-La Roche
                8.4.5.1 Business Description
                8.4.5.2 F. Hoffmann-La Roche Geographic Operations
                8.4.5.3 F. Hoffmann-La Roche Financial Information
                8.4.5.4 F. Hoffmann-La Roche Product Positions/Portfolio
                8.4.5.5 F. Hoffmann-La Roche Key Developments
        8.4.6 GlaxoSmithKline plc.
                8.4.6.1 Business Description
                8.4.6.2 GlaxoSmithKline plc. Geographic Operations
                8.4.6.3 GlaxoSmithKline plc. Financial Information
                8.4.6.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.6.5 GlaxoSmithKline plc. Key Developments
        8.4.7 Johnson & Johnson Services, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Johnson & Johnson Services, Inc. Geographic Operations
                8.4.7.3 Johnson & Johnson Services, Inc. Financial Information
                8.4.7.4 Johnson & Johnson Services, Inc. Product Positions/Portfolio
                8.4.7.5 Johnson & Johnson Services, Inc. Key Developments
        8.4.8 Merck & Co., Inc.
                8.4.8.1 Business Description
                8.4.8.2 Merck & Co., Inc. Geographic Operations
                8.4.8.3 Merck & Co., Inc. Financial Information
                8.4.8.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.8.5 Merck & Co., Inc. Key Developments
        8.4.9 Mylan N.V
                8.4.9.1 Business Description
                8.4.9.2 Mylan N.V Geographic Operations
                8.4.9.3 Mylan N.V Financial Information
                8.4.9.4 Mylan N.V Product Positions/Portfolio
                8.4.9.5 Mylan N.V Key Developments
        8.4.10 Novartis AG
                8.4.10.1 Business Description
                8.4.10.2 Novartis AG Geographic Operations
                8.4.10.3 Novartis AG Financial Information
                8.4.10.4 Novartis AG Product Positions/Portfolio
                8.4.10.5 Novartis AG Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Antivirals Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Antivirals Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Antivirals Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Antivirals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Antivirals Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Antivirals Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Antivirals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Antivirals Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Antivirals Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Antivirals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Antivirals Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Antivirals Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Antivirals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Antivirals Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Antivirals Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Antivirals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Antivirals: Market Segmentation 
FIG. 2 Global Antivirals Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Antivirals Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Antivirals Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Antivirals Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Antivirals Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Antivirals Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Antivirals Providers, 2019
FIG. 11 Global Antivirals Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Antivirals Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Antivirals Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Antivirals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Antivirals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Antivirals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Antivirals Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Antivirals Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Antivirals market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Antivirals Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Antivirals Market Value, By Segment1, 2018 – 2028
TABLE  North America Antivirals Market Value, By Segment2, 2018 – 2028
TABLE  North America Antivirals Market Value, By Country, 2018 – 2028
TABLE  Europe Antivirals Market Value, By Segment1, 2018 – 2028
TABLE  Europe Antivirals Market Value, By Segment2, 2018 – 2028
TABLE  Europe Antivirals Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Antivirals Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Antivirals Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Antivirals Market Value, By Country, 2018 – 2028
TABLE  Latin America Antivirals Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Antivirals Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Antivirals Market Value, By Country, 2018 – 2028
TABLE  MEA Antivirals Market Value, By Segment1, 2018 – 2028
TABLE  MEA Antivirals Market Value, By Segment2, 2018 – 2028
TABLE  MEA Antivirals Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers-Squibb: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Broad Institute: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Services, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Antivirals Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Antivirals Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Antivirals Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Antivirals Market, By Geography, 2019 (US$ Mn)
FIG.  Global Antivirals Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Antivirals Providers, 2016
FIG.  Global Antivirals Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Electrosurgical Generator Systems Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antivirals Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ambulatory Surgical Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ASCs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Antivirals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Antivirals Market Value, 2018 – 2028, (US$ Mn)